Gene Variants That Protect Against Alzheimer Disease Could Increase Risk of AMD
December 1st 2022The risk of age-related macular degeneration (AMD) could be linked to structural variations in the APOE gene that were previously found to be associated with protection against Alzheimer disease.
Read More
The Biden administration plans to end the national emergency that was called for the monkeypox virus outbreak as cases appear to be under control; bisexual and gay men will more easily be able to donate blood under new guidelines set to be released by the FDA; the FDA has paused the emergency use authorization for the monoclonal antibody treatment bebtelovimab.
Read More
Contributor: On World AIDS Day—Lessons Drawn From HIV, Monkeypox, and COVID-19
December 1st 2022Dr Halkitis is currently working on his new book "People, Politics, & Public Health: How the American People Created the HIV, COVID-19, and Other Modern-Day Pandemics," to be published by Johns Hopkins University Press.
Read More
BMI Implicated in Glucocorticoid Insensitivity in CRSwNP
November 30th 2022The investigators of this study compared outcomes between patients who had eosinophilic or noneosinophilic chronic rhinosinusitis with nasal polyps (CRSwNP) by comparing the influence of body mass index (BMI) on each disease subtype.
Read More
As of November 23, Twitter is no longer enforcing its COVID-19 misinformation policy; CDC awards more than $3 billion to strengthen the public health infrastructure and workforce; lecanemab appears to slow the spread of Alzheimer disease but is linked to multiple adverse events, symptoms, and deaths.
Read More
HDHPs Deter Women From Additional Testing After Abnormal Mammogram, Study Says
November 29th 2022The groups who told researchers they would be more likely to skip additional testing had lower levels of income or education and were more likely to be on Medicaid or be uninsured, among other factors.
Read More
Lack of Knowledge Continues to Influence Delayed Melanoma Diagnosis
November 29th 2022Malignant cutaneous melanoma outcomes were investigated as they relate to diagnosis delay and potential influence from socioeconomic and demographic factors in Brazil, where skin cancer diagnoses represent 30% of all cancer diagnoses.
Read More
US flu hospitalizations increased nearly 30% in the week before Thanksgiving; HHS proposed a rule to align 42 CFR Part 2 privacy protections with existing law to protect patients with substance abuse disorder; New York State saw a decline in opioid prescriptions during the first month of COVID-19 lockdowns.
Read More
Predictors of Severe COVID-19 Infection, Mortality in Patients With MM, AL Identified
November 29th 2022Their findings, say the researchers, offer useful insights into the outcomes and risks of severe disease and mortality in patients who have multiple myeloma (MM) or amyloidosis (AL) with underlying monoclonal gammopathy who contract COVID-19.
Read More
Potential for ICI-Related Arrhythmias Necessitates Recognizing Risk Early
November 29th 2022Researchers pulled data from the FDA’s Adverse Event Reporting System to analyze cardiac arrhythmia–related outcomes among patients on a mono or combination regimen for cancer treatment that included immune checkpoint inhibitors (ICIs).
Read More
Women With CKD Receiving Fertility Treatment Have Similar Birth Rates to Those Conceiving Naturally
November 28th 2022Researchers underscore a need for prospective data, noting that women with chronic kidney disease (CKD) tended to have higher rates of preterm delivery and lower birthweight.
Read More
MDD Treatment Alternatives Explore Potential of Cannabis, Psychedelics
November 28th 2022Stemming from recent data on a potential link between major depressive disorder (MDD) and inflammation, research is starting to turn toward alternatives that can treat the disease through anti-inflammatory effects, including ketamine, cannabinoids, and psychedelics.
Read More
CBD May Improve Neurologic, Cognitive, QOL Outcomes in Sturge-Weber Syndrome
November 28th 2022A small, prospective, open-label trial found evidence of improved quality of life (QOL) and clinical outcomes among patients with treatment-resistant Sturge-Weber syndrome when they were treated with CBD.
Read More